| Announce Date | 08/08/2025 |
| EPS Normalized Actual | $-0.07 (Beat by $0.2) |
| EPS GAAP Actual | $-0.07 (Beat by $0.2) |
| Revenue Actual | $0.019525B |
| Revenue Surprise | Beat by $19.525M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.1133 |
| EPS GAAP Estimate | $-0.1133 |
| Revenue Estimate | $0.0262433B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | -1.29 | -6.67 | -1.65762 | -1.11008 | 3 |
| Dec 2028 | -0.1 | -86.1 | -0.10691 | -0.09671737 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.0715 | -0.0376 | 0.019525B | -16.76% | -10.54M |
| FQ1 2025 (Mar 2025) | -0.12 | -0.0486 | 0.020904B | 4.65% | -7.09M |
| FQ4 2024 (Dec 2024) | -0.15 | -0.03106 | 0.026495B | 11.82% | 1.15M |
| FQ3 2024 (Sep 2024) | -0.16 | -0.05064 | 0.018461B | -10.8% | -5.68M |
| FQ2 2024 (Jun 2024) | -0.21 | -1.55259 | 0.022798B | 8.98% | -18.7M |
| FQ1 2017 (Mar 2017) | -0.17 | -0.17 | 0B | NAN% | 0M |
| FQ2 2017 (Jun 2017) | -0.17 | -0.17 | 0B | NAN% | 0M |
| FQ1 2024 (Mar 2024) | -0.15 | -0.15 | 0.019931B | -1.61% | 19.93M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.1133
Consensus Revenue Estimates
0.0262433B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | -0.0309 | -- | -0.03796705 | -0.02715829 | 1 |
| FQ3 2026 (Sep 2026) | -0.177 | -- | -0.21748 | -0.15557 | 1 |
| FQ2 2026 (Jun 2026) | -0.1794 | 60.14 | -0.22043 | -0.15768 | 1 |
| FQ1 2026 (Mar 2026) | -0.1133 | -5.91 | -0.13921 | -0.09958041 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.03B | -- | 0.03B | 0.04B | 4 |
| FQ3 2026 (Sep 2026) | 0.03B | -- | 0.02B | 0.03B | 4 |
| FQ2 2026 (Jun 2026) | 0.03B | 35.87 | 0.03B | 0.04B | 4 |
| FQ1 2026 (Mar 2026) | 0.03B | 20.35 | 0.02B | 0.03B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
2
Revenue # of Misses
4
Revenue # of in-lines
2
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.0339 | -0.0715 | -0.0376 | 52.59% |
| FQ1 2025 (Mar 2025) | -0.0714 | -0.12 | -0.0486 | 40.5% |
| FQ4 2024 (Dec 2024) | -0.11894 | -0.15 | -0.03106 | 20.71% |
| FQ3 2024 (Sep 2024) | -0.10936 | -0.16 | -0.05064 | 31.65% |
| FQ2 2024 (Jun 2024) | 1.34259 | -0.21 | -1.55259 | 739.33% |
| FQ1 2017 (Mar 2017) | -0.17 | -0.17 | 100% | |
| FQ2 2017 (Jun 2017) | -0.17 | -0.17 | 100% | |
| FQ1 2024 (Mar 2024) | -0.15 | -0.15 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0.03B | $0.02B | $-10.54M | -53.99% |
| FQ1 2025 (Mar 2025) | $0.03B | $0.02B | $-7.09M | -33.91% |
| FQ4 2024 (Dec 2024) | $0.03B | $0.03B | $1.15M | 4.33% |
| FQ3 2024 (Sep 2024) | $0.02B | $0.02B | $-5.68M | -30.78% |
| FQ2 2024 (Jun 2024) | $0.04B | $0.02B | $-18.7M | -82.04% |
| FQ1 2017 (Mar 2017) | $0B | $0B | $0M | NAN% |
| FQ2 2017 (Jun 2017) | $0B | $0B | $0M | NAN% |
| FQ1 2024 (Mar 2024) | $0B | $0.02B | $19.93M | 100% |